Variant NM_000492.4:c.4357C>T


Variant details:
Name NM_000492.4:c.4357C>T
Protein name NP_000483.3:p.(Arg1453Trp)
Genomic name (hg19) chr7:g.117307076C>T    UCSC    
#Exon/intron exon 27
Legacy Name R1453W
Class VUS
WT sequence CGACAGGGTGAAGCTCTTTCCCCAC C GGAACTCAAGCAAGTGCAAGTCTAA
Mutant sequence CGACAGGGTGAAGCTCTTTCCCCAC T GGAACTCAAGCAAGTGCAAGTCTAA

Other databases:

Not found
dbSNP
rs4148725



Pathogenicity predictors:


Reference PMID Splicing mRNA level Maturation Localization Channel fonction (Cl-) Bicarbonate
Lee et al, 2003 12952861


« ✓ » indicates the type of analysis performed and not the results




No patient found in CFTR-NGS catalogue


1 patients carrying this variant are reported in CFTR-France:

TOTAL NUMBER OF PATIENTS 1
CFTR-RD1
  • CBAVD  1




Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing

Detailed genotypes:
Phenotype Patient ID Variant status Additional variants
CBAVD 5379heterozygoteVUS3- Undef


Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing



            CFTR variants are clustered into five groups:
  • CF-causing: when in trans with another CF-causing mutation, will result in CF.
  • CFTR-RD causing: when in trans with a CF-causing mutation, will result in CFTR-related disorders (CFTR-RD) such as chronic pancreatitis, bronchiectasis, CRS-NP (chronic rhinosinusitis with or without nasal polyposis) or CBAVD (congenital absence of vas deferens), according to Bombieri C et al., 2011.
  • Varying clinical consequence: when in trans with another CF-causing mutation, can either result in CF or in a CFTR-RD.
  • Non disease-causing: when in trans with a CF-causing mutation, will not cause CF, nor CFTR-RD.
  • VUS (Variant of unknown clinical significance): unclassified because of insufficient data.



Go to CFTRare